Sphera Funds Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Sphera Funds Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-32,300	Closed	-$264K	–	123
2016 Q1	$264K	Sell	32,300 -155,322	-83%	-$1.17M	0.06%	88
2015 Q4	$1.89M	Buy	187,622 +50,000	+36%	+$519K	0.28%	89
2015 Q3	$1.33M	Hold	137,622	–	–	0.17%	111
2015 Q2	$2.37M	Buy	+137,622	New	+$2.01M	0.23%	105
2014 Q2	–	Sell	-22,222	Closed	-$2.5M	–	144
2014 Q1	$2.5M	Buy	+22,222	New	+$1.56M	0.57%	35

Other funds holding TBRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Sphera Funds Management's TBRA Position: Q2 2016 in Review

Sphera Funds Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q2 2016, closing a stake of 32,300 shares — an estimated $264K sold.

Sphera Funds Management first reported a position in TBRA in Q1 2014 and held it in 5 quarters. The position peaked at $2.5M in Q1 2014. 45 funds tracked by Wall St. Rank hold TBRA as of Q2 2016.

Sphera Funds Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Sphera Funds Management sold 32,300 Tobira Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $264K.
Sphera Funds Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 5 quarters.
Sphera Funds Management's Tobira Therapeutics, Inc. Common Stock position peaked at $2.5M in Q1 2014.
45 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Sphera Funds Management's 13F filing for Q2 2016, filed 10 Aug 2016.